Lv3
360 积分 2025-03-21 加入
Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors
12小时前
待确认
Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis
13小时前
已完结
THU0080 PRECLINICAL CHARACTERIZATION OF TLL018, A NOVEL, HIGHLY POTENT AND SELECTIVE JAK1/TYK2 INHIBITOR FOR TREATING AUTOIMMUNE DISEASES
17小时前
已完结
Deep seeking covalent DNA encoded library for novel JAK3 inhibitor discovery
20小时前
已完结
Targeting the Tyrosine Kinase 2 (TYK2) Pseudokinase Domain: Discovery of the Selective TYK2 Inhibitor ABBV-712
21小时前
已完结
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms
21小时前
已完结
Synthesis of Stereoisomeric Analogues of Endomorphin-2, H-Tyr-Pro-Phe-Phe-NH2, and Examination of Their Opioid Receptor Binding Activities and Solution Conformation
9天前
已完结
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells
16天前
已完结
Bacterial Preparation of Enantiopure Unactivated Aziridine-2-carboxamides and Their Transformation into Enantiopure Nonnatural Amino Acids and vic-Diamines
19天前
已完结
[2+2+1+1] Cycloaddition Reaction of 1,3,5‐Triazinanes with Methylene Compounds: Approach to Hexahydropyrimidines
23天前
已完结
皖公网安备34019202002308
